Hub
Hudson River raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications
Hudson
River
raises
€5m
Series
A
funding
to
accelerate
growth
of
its
plant
gene
editing
business
and
expand
into
nanoparticles
for
use
in
field
applications
10.12.2022
Press
Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the forefront of technological developments. This funding is another building block, which will allow us to further scale up the existing gene editing business.” Additionally, HRB will grow its staff count from 25 to 40 in the next 12 months and increase its laboratory space to some 1000 square meters (10600 sq.ft.).